Clinical Trials · NCT04916470
Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 617
- Start date
- Jun 2021
- Locations
- 180 sites, 16 countries
- Primary endpoint
- Change in KCCQ (Kansas City Cardiomyopathy Questionnaire) clinical summary score